Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IGC Pharma (IGC) Other financing activities (2017 - 2018)

IGC Pharma (IGC) has disclosed Other financing activities for 3 consecutive years, with $79747.0 as the latest value for Q1 2018.

  • On a quarterly basis, Other financing activities changed N/A to $79747.0 in Q1 2018 year-over-year; TTM through Mar 2018 was $114393.0, a 114.24% increase, with the full-year FY2018 number at $191000.0, changed N/A from a year prior.
  • Other financing activities was $79747.0 for Q1 2018 at IGC Pharma, up from $34646.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $79747.0 in Q1 2018 to a low of $34646.0 in Q2 2017.